Could a placental protein unlock the mystery of preeclampsia?

NCT ID NCT07745036

Recruiting now Knowledge-focused Sponsor: Samsun University Source: ClinicalTrials.gov ↗

First seen Aug 04, 2026 · Last updated Aug 05, 2026 · Updated 1 time

Summary

This study investigates whether certain progesterone receptors in the placenta are linked to preeclampsia, a serious pregnancy condition marked by high blood pressure. Researchers will compare placental tissue from women with preeclampsia to that from healthy pregnant women, measuring the levels of specific receptors. The goal is to better understand the molecular causes of preeclampsia, which could eventually lead to improved prevention or treatment.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to: If this study finds a link, it could point toward new ways to predict or treat preeclampsia, a serious pregnancy complication.
What could go wrong: This is an observational study, so it can only show associations, not cause and effect. The findings may not lead directly to treatments.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for PREECLAMPSIA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

preeclampsia

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

PREECLAMPSIA PREECLAMPSIA COMPLICATIONS

Contacts and locations

Locations

Samsun University Faculty of Medicine Samsun Training and Research Hospital
RECRUITING

Samsun, Turkey (Türkiye)

More trials for these conditions

Other studies related to the condition(s) this trial covers.